Estudo piloto da penetraçäo da fenotipagem HLA-lócus DR nos pacientes com artrite reumatóide em Recife, Pernambuco

Cavalcanti, Fernando S; Araújo, Maria Helena Q. de; Valadares, Lilian D. Azevedo; Leite, Maria Socorro Silva; Freitas, Geraldo Gomes de.
Rev. bras. reumatol ; 31(4): 127-8, jul.-ago. 1991.
Artículo en Portugués | LILACS | ID: lil-120570

Documentos relacionados

  1. Protection against anti-citrullinated protein antibody-positive rheumatoid arthritis is predominantly associated with HLA-DRB1*1301: a meta-analysis of HLA-DRB1 associations with anti-citrullinated protein antibody-positive and anti-citrullinated protein antibody-negative rheumatoid arthritis in four European populations.
  2. Putative amino acid sequence of HLA-DRB chain contributing to rheumatoid arthritis susceptibility.
  3. Functional categorization of HLA-DRB1 alleles in rheumatoid arthritis: the protective effect.
  4. Individual and population-level variability in HLA-DR associated immunogenicity risk of biologics used for the treatment of rheumatoid arthritis.
  5. The role of posttranslational modifications in generating neo-epitopes that bind to rheumatoid arthritis-associated HLA-DR alleles and promote autoimmune T cell responses.
  6. Hormonal replacement therapy may reduce the risk for RA in women with early arthritis who carry HLA-DRB1 *01 and/or *04 alleles by protecting against the production of anti-CCP: results from the ESPOIR cohort.
  7. Is there an indication for HLA-DR typing for individual patients with rheumatoid arthritis?
  8. Heat shock proteins, HLA-DR and rheumatoid arthritis.
  9. HLA class II and rheumatoid arthritis: the bumpy road of revelation.
  10. Human leukocyte antigen-DQ and DR polymorphisms predict rheumatoid arthritis outcome better than DR alone.